UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies

Frontiers in immunology, 2020-06, Vol.11, p.1185

2020

Volltextzugriff (PDF)

Decreased BDNF, trkB-TK+ and GAD67 mRNA Expression in the Hippocampus of Individuals with Schizophrenia and Mood Disorders

Journal of psychiatry & neuroscience, 2011-05, Vol.36 (3), p.195-203

2011

Volltextzugriff (PDF)

Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic

Circulation (New York, N.Y.), 2017-09, Vol.136 (11), p.979-981

2017

Volltextzugriff (PDF)

A role for alternative splicing in circadian control of exocytosis and glucose homeostasis

Genes & development, 2020-08, Vol.34 (15-16), p.1089-1105

2020

Volltextzugriff (PDF)

Welcome to the splice age: antisense oligonucleotide-mediated exon skipping gains wider applicability

The Journal of clinical investigation, 2016-04, Vol.126 (4), p.1236-1238

2016

Volltextzugriff (PDF)

A gene-edited mouse model of limb-girdle muscular dystrophy 2C for testing exon skipping

Disease models & mechanisms, 2020-02, Vol.13 (2)

2020

Volltextzugriff (PDF)

Erratum: A role for alternative splicing in circadian control of exocytosis and glucose homeostasis

Genes & development, 2021-03, Vol.35 (5-6), p.425-425

2021

Volltextzugriff (PDF)

Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production

EMBO molecular medicine, 2012-07, Vol.4 (7), p.633-646

2012

Volltextzugriff (PDF)

Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease

Skeletal muscle, 2016-09, Vol.6 (1), p.32-32, Article 32

2016

Volltextzugriff (PDF)

Reduction in Hexokinase II Levels Results in Decreased Cardiac Function and Altered Remodeling After Ischemia/Reperfusion Injury

Circulation research, 2011-01, Vol.108 (1), p.60-69

2011

Volltextzugriff (PDF)

Regulation and cytoprotective role of hexokinase III

PloS one, 2010-11, Vol.5 (11), p.e13823

2010

Volltextzugriff (PDF)

Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes

JCI insight, 2019-03, Vol.4 (6)

2019

Volltextzugriff (PDF)

Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers

JCI insight, 2018-05, Vol.3 (9)

2018

Volltextzugriff (PDF)

Meeting Report: New Directions in Biology and Disease of Skeletal Muscle 2014

Journal of neuromuscular diseases, 2014, Vol.1 (2), p.197-206

2014

Volltextzugriff (PDF)

Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders

Journal of psychiatric research, 2009-07, Vol.43 (11), p.970-977

2009

Volltextzugriff (PDF)

JUN Regulation of Injury-Induced Enhancers in Schwann Cells

The Journal of neuroscience, 2022-08, Vol.42 (34), p.6506-6517

2022

Volltextzugriff (PDF)

Decreased glutamic acid decarboxylase67 mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders

Journal of psychiatric research, 2009-07, Vol.43 (11), p.970-977

2009

Volltextzugriff (PDF)

Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping

The Journal of clinical investigation, 2015-11, Vol.125 (11), p.4186-4195

2015

Volltextzugriff (PDF)

Abstract P214: Reduction of Hexokinase II Exaggerated Cardiac Hypertrophy via Increased ROS Production and Mitochondrial Permeability Transition

Circulation research, 2011-12, Vol.109 (suppl_1)

2011

Volltextzugriff (PDF)

Decreased glutamic acid decarboxylase 67 mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders

Journal of psychiatric research, 2009, Vol.43 (11), p.970-977

2009

Volltextzugriff (PDF)

Meeting Report: New Directions in Biology and Disease of Skeletal Muscle 2014

Journal of neuromuscular diseases, 2014, Vol.1 (2), p.197

2014

Volltextzugriff (PDF)

Decreased BDNF, trkB-TK+ and [GAD.sub.67] mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders

Journal of psychiatry & neuroscience, 2011-05, Vol.36 (3), p.195

2011

Volltextzugriff (PDF)

Decreased BDNF, trkB-TK+ and GAD^sub 67^ mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders

Journal of psychiatry & neuroscience, 2011-05, Vol.36 (3), p.195

2011

Volltextzugriff (PDF)

Decreased BDNF, trkB-TK+ and GAD sub( 67) mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders

Journal of psychiatry & neuroscience, 2011-05, Vol.36 (3), p.195-195

2011

Volltextzugriff (PDF)

Decreased BDNF, trkB-TK+ and GAD 67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders

Journal of psychiatry & neuroscience, 2011-05, Vol.36 (3), p.195-203

2011

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(67)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(88)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies

Decreased BDNF, trkB-TK+ and GAD67 mRNA Expression in the Hippocampus of Individuals with Schizophrenia and Mood Disorders

Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic

A role for alternative splicing in circadian control of exocytosis and glucose homeostasis

Welcome to the splice age: antisense oligonucleotide-mediated exon skipping gains wider applicability

A gene-edited mouse model of limb-girdle muscular dystrophy 2C for testing exon skipping

Erratum: A role for alternative splicing in circadian control of exocytosis and glucose homeostasis

Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production

Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease

Reduction in Hexokinase II Levels Results in Decreased Cardiac Function and Altered Remodeling After Ischemia/Reperfusion Injury

Regulation and cytoprotective role of hexokinase III

Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes

Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers

Meeting Report: New Directions in Biology and Disease of Skeletal Muscle 2014

Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders

JUN Regulation of Injury-Induced Enhancers in Schwann Cells

Decreased glutamic acid decarboxylase67 mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders

Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping

Abstract P214: Reduction of Hexokinase II Exaggerated Cardiac Hypertrophy via Increased ROS Production and Mitochondrial Permeability Transition

Decreased glutamic acid decarboxylase 67 mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders

Meeting Report: New Directions in Biology and Disease of Skeletal Muscle 2014

Decreased BDNF, trkB-TK+ and [GAD.sub.67] mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders

Decreased BDNF, trkB-TK+ and GAD^sub 67^ mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders

Decreased BDNF, trkB-TK+ and GAD sub( 67) mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders

Decreased BDNF, trkB-TK+ and GAD 67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders

Suchergebnisse filtern